SSRI use during pregnancy and risk of stillbirth and neonatal mortality

American Journal of Psychiatry

Volumn 170, Issue 3, 2013, Pages 299-304

  Jimenez Solem, Espen ^a   Andersen, Jon Trærup ^a   Petersen, Morten ^a   Broedbaek, Kasper ^a   Lander, Anders Rune ^a   Afzal, Shoaib ^a   Torp Pedersen, Christian ^a   Poulsen, Henrik E ^a  

^a not available ^*

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MORTALITY; POPULATION RESEARCH; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; STILLBIRTH; THIRD TRIMESTER PREGNANCY;

EID: 84874768520     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.11081251     Document Type: Article

References (32)

1. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R: Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194.e1-194.e5
2. Bakker MK, Kölling P, Van Den Berg PB, De Walle HE, De Jong Van Den Berg LT: Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade: a populationbased cohort study from the Netherlands. Br J Clin Pharmacol 2008;65:600-606 (Pubitemid 351365128)
3. Cooper WO, Willy ME, Pont SJ, Ray WA: Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007;196:544-545, e1-e5
4. Wichman CL, Fothergill A, Moore KM, Lang TR, Heise RH Jr, Watson WJ: Recent trends in selective serotonin reuptake inhibitor use in pregnancy. J Clin Psychopharmacol 2008;28:714-716
5. Danish Health and Medicines Authority: Risk of death or serious side effects in newborns following exposure to antidepressants (fluoxetine and other SSRIs). March 1, 2011 (http://laegemiddelstyrelsen. dk/en/topics/side-effects- and-trials/sideeffects/news/risk-of-death-or-serious-side-effects-in-ther-ssris)
6. Danish Health and Medicines Authority: Data on deaths or serious side effects in newborns from use of antidepressants (SSRIs). March 14, 2011. (http://laegemiddelstyrelsen. dk/en/topics/sideeffects-and-trials/side-effects/ news/data-on-deaths-or-serious-sideeffects-i-ants-ssris)
7. Källén BA, Otterblad Olausson P: Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007;79:301-308 (Pubitemid 46980405)
8. Lennestål RM, Källén BM: Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 2007;27:607-613
9. Nordeng H, Lindemann R, Perminov KV, Reikvam A: Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001;90:288-291 (Pubitemid 32299548)
10. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB: The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull 2006;53:441-449 (Pubitemid 44816920)
11. Knudsen LB: The Danish Fertility Database. Dan Med Bull 1998;45:221-225 (Pubitemid 28183950)
12. Gaist D, Sørensen HT, Hallas J: The Danish prescription registries. Dan Med Bull 1997;44:445-448 (Pubitemid 27382061)
13. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH: The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-268 (Pubitemid 29299976)
14. Fosbøl EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, Folke F, Sørensen R, Rasmussen JN, Køber L, Madsen M, Torp-Pedersen C: The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf 2008;17:822-833
15. Knudsen LB, Børlum Kristensen F: Monitoring perinatal mortality and perinatal care with a national register: content and usage of the Danish Medical Birth Register. Community Med 1986;8:29-36 (Pubitemid 16136395)
16. Olesen C, Søndergaard C, Thrane N, Nielsen GL, De Jong-Van Den Berg L, Olsen J; EuroMAP Group: Do pregnant women report use of dispensed medications? Epidemiology 2001;12:497-501 (Pubitemid 32761987)
17. Sørensen HT, Hansen I, Ejlersen E, Sabroe S, Hamburger H: Identification of patients treated with strong analgesics: an assessment of two Danish information systems with respect to epidemiological research. J Med Syst 1996;20:57-65 (Pubitemid 26118717)
18. Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Jensen JK, Afzal S, Gislason GH, Torp-Pedersen C, Poulsen HE: Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012;2:e001148
19. Cedergren MI: Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004;103:219-224
20. Bakker MK, Kerstjens-Frederikse WS, Buys CH, De Walle HE, De Jong-Van Den Berg LT: First-trimester use of paroxetine and congenital heart defects: a population-based casecontrol study. Birth Defects Res A Clin Mol Teratol 2010;88:94-100
21. Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics: Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007;16:1086-1094 (Pubitemid 350020061)
22. Goldstein DJ, Corbin LA, Sundell KL: Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997;89:713-718 (Pubitemid 27184852)
23. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, Ormond K, Matsui D, Stein-Schechman AK, Cook L, Brochu J, Rieder M, Koren G: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998;279:609-610 (Pubitemid 28110208)
24. Malm H, Klaukka T, Neuvonen PJ: Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005;106:1289-1296 (Pubitemid 41668948)
25. Sivojelezova A, Shuhaiber S, Sarkissian L, Einarson A, Koren G: Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005;193:2004-2009 (Pubitemid 41737626)
26. Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, Walker M: Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006;194:961-966
27. Richelson E: Synaptic effects of antidepressants. J Clin Psychopharmacol 1996;16(suppl 2):1S-7S
28. Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH: Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009;339:b3569
29. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J: Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007;164:1206-1213 (Pubitemid 47292409)
30. Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT: Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009;166:557-566
31. Källén B, Olausson PO: Maternal use of selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2008;17:801-806
32. Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G: Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther 2007;29:918-926 (Pubitemid 47223423)